Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04248465 |
|---|---|
| Brief Title: | An Efficacy and Safety Study of Ravulizumab in ALS Participants |
| First Submitted : | January 27, 2020 |
| First Submitted that Met QC Criteria : | January 29, 2020 |
| First Posted : | January 30, 2020 |
| Results First Submitted : | September 22, 2022 |
| Results First Posted with QC Comments : | October 21, 2022 |
| Results First Submitted that Met QC Criteria : | December 15, 2022 |
| Results First Posted : | January 10, 2023 |
| Last Update Submitted that Met QC Criteria : | December 15, 2022 |
| Last Update Posted : | January 10, 2023 |